OECD Home › Directorate for Science, Technology and Industry › Latest Documents
This report takes an initial look at methodologies to measure and estimate the monetary value of personal data, which is creating economic and social value at an increasing pace. But measuring and estimating its value is difficult. This is because not only a huge amount of personal data is being generated, but also as it is used in many different situations and for numerous purposes.
This policy paper provides new evidence on the link of labour market regulation, bankruptcy legislation, financial market development and R&D support policies with growth dynamics. The study goes beyond looking at differences in average growth rates as it analyses changes in the whole distribution of firms.
The growing awareness that knowledge-based capital (KBC) is driving economic growth is prevalent in today’s global marketplace. The creation and application of knowledge is especially critical to the ability of firms and organisations to develop in a competitive global economy and to create high-wage employment.
While consumer demand for digital goods has increased rapidly in recent years, a range of challenges undermine confidence in the market and require policy attention.
OECD Global Science Forum report on data and research infrastructure for the social sciences.
English, PDF, 937kb
This document presents a project proposal with the aim of conducting a forward-looking assessment of the ocean economy to 2030 and beyond, with particular emphasis on the development potential of emerging ocean-based industries.
This report examines "open access" policies and approaches in various contexts, including fixed and mobile access networks, backhaul and backbone networks, undersea cables and Internet exchange points (IXPs).
Although the market for green goods and services is growing, the development of new business models is affected by a range of barriers, many of which can be addressed by well-designed policies.
This framework introduces a risk-based oversight and management methodology for clinical trials. It combines a stratified approach that is based on the marketing authorisation status of the medical product and can be applied in a common manner across countries’ regulatory frameworks, with a trial-specific approach that considers other issues such as the type of populations concerned by the trial, or the informed consent of the patients.
Increasingly complex and inconsistent clinical trial regulations are causing delays, raising costs and leading to a decline in the number of international trials conducted by academics for non-commerical purposes.